The White House scrapped plans to hold a meeting today at a Baltimore-based vaccine plant run by Emergent BioSolutions following an exposé from The New York Times. The Biden administration also announced plans to conduct an audit of the Strategic National Stockpile after the publication of the article, which described how the biopharmaceutical company lobbied…